Status:
COMPLETED
Hyperbaric Oxygen Therapy in Diabetic Foot
Lead Sponsor:
National Polytechnic Institute, Mexico
Conditions:
Diabetic Foot Ulcer Neuropathic
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to assess changes in genes that are related to inflammation and oxidative stress in patients with type 2 Diabetes with diabetic foot treated with hyperbaric chamber
Detailed Description
Aims: Patients with an uncontrolled glycemic index develop a wide variety of pathologies associated with diabetes, such as diabetic foot ulcers (DFUs). Hyperbaric oxygen therapy (HBOT) is an adjunctiv...
Eligibility Criteria
Inclusion
- Men and women with diabetic foot and hyperbaric treatment. Ages 30-60 years. Signed informed consent form.
Exclusion
- Patients with diabetic foot without presence of dermatologic lesions.
Key Trial Info
Start Date :
January 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06502808
Start Date
January 15 2019
End Date
July 15 2020
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Modesto Gómez López
Mexico City, Mexico City, Mexico, 11340